Published in Biophys J on November 01, 2000
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature (1984) 9.22
Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol (1987) 5.22
The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture. J Physiol (1988) 4.91
Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron (1992) 4.53
Molecular cloning and characterization of the rat NMDA receptor. Nature (1991) 4.45
Nonuniform probability of glutamate release at a hippocampal synapse. Science (1993) 4.23
Molecular diversity of the NMDA receptor channel. Nature (1992) 3.76
Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A (1988) 3.31
Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents. Nature (1990) 3.14
Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J Physiol (1990) 2.97
Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev (1989) 2.82
Fractional contribution of calcium to the cation current through glutamate receptor channels. Neuron (1993) 2.69
Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science (1992) 2.64
Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron (1996) 2.05
Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels. J Neurosci (1992) 1.76
Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron (1995) 1.76
Coupling of permeation and gating in an NMDA-channel pore mutant. Neuron (1997) 1.70
Identification by mutagenesis of a Mg(2+)-block site of the NMDA receptor channel. Nature (1992) 1.68
Identification of a high affinity divalent cation binding site near the entrance of the NMDA receptor channel. Neuron (1996) 1.56
NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines. Neuron (1999) 1.39
Ionic permeability characteristics of the N-methyl-D-aspartate receptor channel. J Gen Physiol (1994) 1.36
Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique. J Neurophysiol (1988) 1.33
Trapping of glutamate and glycine during open channel block of rat hippocampal neuron NMDA receptors by 9-aminoacridine. J Physiol (1995) 1.24
Single channel properties of cloned NMDA receptors in a human cell line: comparison with results from Xenopus oocytes. J Physiol (1994) 1.14
The selectivity filter of the N-methyl-D-aspartate receptor: a tryptophan residue controls block and permeation of Mg2+. Mol Pharmacol (1998) 1.12
Interactions between two divalent ion binding sites in N-methyl-D-aspartate receptor channels. Proc Natl Acad Sci U S A (1996) 1.09
Different mechanisms of Ca2+ transport in NMDA and Ca2+-permeable AMPA glutamate receptor channels. J Gen Physiol (1998) 0.98
A single tryptophan on M2 of glutamate receptor channels confers high permeability to divalent cations. Biophys J (1996) 0.84
Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect Immun (1979) 7.21
Nonuniform probability of glutamate release at a hippocampal synapse. Science (1993) 4.23
Vibrio cholerae adherence and colonization in experimental cholera: electron microscopic studies. Infect Immun (1976) 4.03
Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin. Infect Immun (1978) 3.95
Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli. Infect Immun (1978) 3.80
Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect Immun (1980) 3.36
Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun (1995) 3.22
Subunit number and arrangement in Escherichia coli heat-labile enterotoxin. Infect Immun (1981) 3.15
Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents. Nature (1990) 3.14
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol (2001) 3.05
Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science (1995) 2.44
Direct measurement of specific membrane capacitance in neurons. Biophys J (2000) 2.39
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med (1998) 2.20
Analysis of a genomic DNA region from the cyanobacterium Synechococcus sp. strain PCC7942 involved in carboxysome assembly and function. J Bacteriol (1993) 2.11
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin Microbiol Rev (1992) 2.02
Mucosal adjuvants. Vaccine (2005) 1.86
Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement. Neuron (2001) 1.72
Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect Immun (1984) 1.70
Immunological and physicochemical characterization of heat-labile enterotoxins isolated from two strains of Escherichia coli. Infect Immun (1982) 1.70
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis (1996) 1.68
Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun (1996) 1.60
Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol (2001) 1.59
Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine (1998) 1.58
Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones. J Physiol (1990) 1.52
Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin. Infect Immun (1982) 1.44
Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infect Immun (1989) 1.43
Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin. Infect Immun (1986) 1.43
Characterization of PitA and PitB from Escherichia coli. J Bacteriol (2001) 1.38
Quantal amplitude and quantal variance of strontium-induced asynchronous EPSCs in rat dentate granule neurons. J Physiol (1999) 1.37
Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin. Infect Immun (1982) 1.36
Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxin. J Infect Dis (1983) 1.29
Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J Virol (1998) 1.29
The proton pore in the Escherichia coli F0F1-ATPase: a requirement for arginine at position 210 of the a-subunit. Biochim Biophys Acta (1987) 1.29
The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine (1999) 1.28
Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infect Immun (1994) 1.25
In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun (1995) 1.24
Photolytic manipulation of [Ca2+]i reveals slow kinetics of potassium channels underlying the afterhyperpolarization in hippocampal pyramidal neurons. J Neurosci (1999) 1.23
Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine (1994) 1.20
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Nonuniform distribution of Ca2+ channel subtypes on presynaptic terminals of excitatory synapses in hippocampal cultures. J Neurosci (1997) 1.18
Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant. Vaccine (1993) 1.17
Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine (1993) 1.17
Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine. Infect Immun (1983) 1.17
Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect Immun (1991) 1.15
N- and P/Q-type Ca2+ channels mediate transmitter release with a similar cooperativity at rat hippocampal autapses. J Neurosci (1998) 1.15
The essential arginine residue at position 210 in the alpha subunit of the Escherichia coli ATP synthase can be transferred to position 252 with partial retention of activity. J Biol Chem (1995) 1.15
Protection in rats immunized with Escherichia coli heat-stable enterotoxin. Infect Immun (1981) 1.13
Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL. J Immunol (2000) 1.13
Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol (1999) 1.13
Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin. Infect Immun (1997) 1.13
Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids. Infect Immun (2001) 1.12
Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli. Infect Immun (1981) 1.11
Postsynaptic expression of long-term potentiation in the rat dentate gyrus demonstrated by variance-mean analysis. J Physiol (1999) 1.09
In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae. Infect Immun (1999) 1.08
Cloning and molecular characterization of the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 1.06
Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect Immun (1996) 1.05
A combination of human alpha 1 and beta 1 subunits is required for formation of detectable GABA-activated chloride channels in Sf9 cells. Proc Biol Sci (1992) 1.05
Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J Virol (2000) 1.03
Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice. Clin Vaccine Immunol (2012) 1.02
Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL-12) but minimal secretion of IL-12 as a 70-kilodalton protein in murine macrophages. Infect Immun (1997) 1.02
Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA. J Virol (2001) 1.02
The proton pore in the Escherichia coli F0F1-ATPase: substitution of glutamate by glutamine at position 219 of the alpha-subunit prevents F0-mediated proton permeability. Biochim Biophys Acta (1988) 1.01
Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae. Mucosal Immunol (2011) 0.98
Intracellular tetraethylammonium ions enhance group Ia excitatory post-synaptic potentials evoked in cat motoneurones. J Physiol (1986) 0.97
Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen. Vaccine (1986) 0.97
Liposomes as vehicles for vaccines. Prog Clin Biol Res (1980) 0.96
Effects of mutating leucine to threonine in the M2 segment of alpha1 and beta1 subunits of GABAA alpha1beta1 receptors. J Membr Biol (1996) 0.95
Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G). Vaccine (2000) 0.95
Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect Immun (1999) 0.94
Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants. Vaccine (2001) 0.93
The subunit delta-subunit b domain of the Escherichia coli F1F0 ATPase. The B subunits interact with F1 as a dimer and through the delta subunit. J Biol Chem (1997) 0.92
Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector. Infect Immun (1993) 0.92
Long-term synaptic plasticity in the honeybee. J Neurophysiol (1997) 0.89
Intracellular distribution of heat-labile enterotoxin in a clinical isolate of Escherichia coli. Infect Immun (1985) 0.89
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine. Vaccine (2002) 0.89
Proline residues in two tightly coupled helices of the sulphate transporter, SHST1, are important for sulphate transport. Biochem J (2001) 0.86
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin. Infect Immun (1984) 0.85
Mucosal T cells induce systemic anergy for oral tolerance. Biochem Biophys Res Commun (1995) 0.85
Evaluation of immunogenicity of an oral Salmonella vaccine expressing recombinant Plasmodium berghei merozoite surface protein-1. Am J Trop Med Hyg (1997) 0.82
Homologous mutations in two diverse sulphate transporters have similar effects. FEBS Lett (2000) 0.81
In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice. Immunology (1996) 0.81
Plasmodium permeomics: membrane transport proteins in the malaria parasite. Curr Top Microbiol Immunol (2005) 0.80
Soiled saris: a vector of disease transmission? Trans R Soc Trop Med Hyg (1986) 0.80
Retracted The chloroplast CF0I subunit can replace the b-subunit of the F0F1-ATPase in a mutant strain of Escherichia coli K12. Biochim Biophys Acta (1990) 0.79
Two threonine residues in the M2 segment of the alpha 1 beta 1 GABAA receptor are critical for ion channel function. Receptors Channels (1998) 0.79
Use of nanocarriers for transdermal vaccine delivery. Clin Pharmacol Ther (2007) 0.78
Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect Immun (1996) 0.78
Opioid-glutamate interactions in rat locus coeruleus neurons. J Neurophysiol (1993) 0.77
Phylogenetic conservation of disulfide-linked, dimeric acetylcholine receptor pentamers in southern ocean electric rays. J Exp Biol (2004) 0.77
Mucosal immune responses induced by transcutaneous vaccines. Curr Top Microbiol Immunol (2012) 0.77
Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G). Med Mycol (2002) 0.77
Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response. Vaccine (2001) 0.76
Glutamate residues at positions 219 and 252 in the a-subunit of the Escherichia coli ATP synthase are not functionally equivalent. Biochim Biophys Acta (1998) 0.76
Surface warfare against pathogens using mucosal vaccines. Nat Biotechnol (1997) 0.76
Reverse transcriptase-polymerase chain reaction amplification and partial sequence of T helper 1- and T helper 2-type lymphokine genes from the owl monkey (Aotus trivirgatus). Am J Trop Med Hyg (1997) 0.75
Computer leasing investments provide two-income families inflation hedge, added revenue. Nephrol Nurse (1982) 0.75